Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia

Nature Genetics

Volumn 43, Issue 3, 2011, Pages 237-241

  Yang, Jun J ^a   Cheng, Cheng ^a   Devidas, Meenakshi ^b   Cao, Xueyuan ^a   Fan, Yiping ^a   Campana, Dario ^a   Yang, Wenjian ^a   Neale, Geoff ^a   Cox, Nancy J ^c   Scheet, Paul ^d   Borowitz, Michael J ^e   Winick, Naomi J ^f   Martin, Paul L ^g   Willman, Cheryl L ^h   Bowman, W Paul ⁱ   Camitta, Bruce M ^j   Carroll, Andrew ^k   Reaman, Gregory H ^l   Carroll, William L ^m   Loh, Mignon ⁿ   Hunger, Stephen P ^o   Pui, Ching Hon ^a   Evans, William E ^a   Relling, Mary V ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF NEW MEXICO   (United States)

ⁱ Cook Children's Medical Center ^*  (United States)

^j MEDICAL COLLEGE OF WISCONSIN   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l GEORGE WASHINGTON UNIVERSITY   (United States)

^m NEW YORK UNIVERSITY   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AFRICAN AMERICAN; AMERICAN INDIAN; ASIAN; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CHILDHOOD CANCER; ETHNICITY; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MALE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRINCIPAL COMPONENT ANALYSIS; RECURRENCE; RISK; SURVIVAL RATE;

EID: 79952188025     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.763     Document Type: Review

References (29)

1. Pui, C.H. & Evans, W.E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166-178 (2006). (Pubitemid 43076714)
2. Carroll, W.L. Race and outcome in childhood acute lymphoblastic leukemia. J. Am. Med. Assoc. 290, 2061-2063 (2003). (Pubitemid 37430591)
3. Kadan-Lottick, N.S., Ness, K.K., Bhatia, S. & Gurney, J.G. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. J. Am. Med. Assoc. 290, 2008-2014 (2003). (Pubitemid 37430583)
4. Bhatia, S. et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100, 1957-1964 (2002). (Pubitemid 35001223)
5. Pollock, B.H. et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J. Clin. Oncol. 18, 813-823 (2000). (Pubitemid 30106612)
6. Pui, C.H. et al. Results of therapy for acute lymphoblastic leukemia in black and white children. J. Am. Med. Assoc. 290, 2001-2007 (2003).
7. Hord, M.H., Smith, T.L., Culbert, S.J., Frankel, L.S. & Pinkel, D.P. Ethnicity and cure rates of Texas children with acute lymphoid leukemia. Cancer 77, 563-569 (1996). (Pubitemid 26047580)
8. Stiller, C.A., Bunch, K.J. & Lewis, I.J. Ethnic group and survival from childhood cancer: report from the UK Children's Cancer Study Group. Br. J. Cancer 82, 1339-1343 (2000). (Pubitemid 30145355)
9. Powell, J.E., Mendez, E., Parkes, S.E. & Mann, J.R. Factors affecting survival in white and Asian children with acute lymphoblastic leukaemia. Br. J. Cancer 82, 1568-1570 (2000). (Pubitemid 30204364)
10. Pui, C.H. et al. Outcome of treatment for childhood cancer in black as compared with white children. The St. Jude Children's Research Hospital experience, 1962 through 1992. J. Am. Med. Assoc. 273, 633-637 (1995).
11. Foucar, K. et al. Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986). Cancer 67, 2125-2130 (1991).
12. Bhatia, S. Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia. Curr. Opin. Pediatr. 16, 9-14 (2004). (Pubitemid 38168155)
13. Mao, X. et al. A genomewide admixture mapping panel for Hispanic/Latino populations. Am. J. Hum. Genet. 80, 1171-1178 (2007). (Pubitemid 47579352)
14. Pritchard, J.K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945-959 (2000). (Pubitemid 30397141)
15. Gaynon, P.S. et al. Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P. Am. J. Pediatr. Hematol. Oncol. 10, 42-50 (1988). (Pubitemid 18063616)
16. Tubergen, D.G. et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group phase III trial. J. Clin. Oncol. 11, 527-537 (1993). (Pubitemid 23071052)
17. Lange, B.J. et al. Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99, 825-833 (2002). (Pubitemid 34525542)
18. Hutchinson, R.J. et al. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J. Clin. Oncol. 21, 1790-1797 (2003). (Pubitemid 46638593)
19. Gaynon, P.S. et al. Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies. J. Clin. Oncol. 19, 1916-1925 (2001). (Pubitemid 32702535)
20. Sankararaman, S., Sridhar, S., Kimmel, G. & Halperin, E. Estimating local ancestry in admixed populations. Am. J. Hum. Genet. 82, 290-303 (2008). (Pubitemid 351726099)
21. Schrappe, M. et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95, 3310-3322 (2000). (Pubitemid 30428458)
22. Borowitz, M.J. et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 111, 5477-5485 (2008).
23. Pui, C.H. et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children's Research Hospital. Blood 104, 2690-2696 (2004).
24. Pui, C.H. et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360, 2730-2741 (2009).
25. Coustan-Smith, E. et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 96, 2691-2696 (2000).
26. Yang, J.J. et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. J. Am. Med. Assoc. 301, 393-403 (2009).
27. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006). (Pubitemid 44141658)
28. Fine, J.P. & Gray, R.J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496-509 (1999).
29. Yeung, K.Y., Fraley, C., Murua, A., Raftery, A.E. & Ruzzo, W.L. Model-based clustering and data transformations for gene expression data. Bioinformatics 17, 977-987 (2001). (Pubitemid 32998635)